Is there a place for clinical registry in present world of EBM? Review article
Article Sidebar
Published:
Dec 31, 2011
Keywords:
clinical registry, GRACE registry, CRUSADE registry, PL-ACS registry, ZAT-POL registry, PURE registry
Main Article Content
Abstract
Patients registry is an observation particularly targeted in describing patients and estimating epidemiology of positive and negative clinical outcomes. Consequently high number of performed clinical registries and appreciation among recommendations’ authors are evidences of registries’ popularity and meaning. Aim of this article is to remind the place of clinical registry in diagnostic and therapeutic proceedings.
Article Details
How to Cite
Cacko, A. (2011). Is there a place for clinical registry in present world of EBM?. Medycyna Faktow (J EBM), 4(4(13), 96-100. Retrieved from https://www.journalsmededu.pl/index.php/jebm/article/view/2509
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. GRACE Investigators: Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am. Heart J. 2001; 141(2): 190-9.
2. Poloński L., Gasior M., Gierlotka M. et al.: Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol. Pol. 2007; 65(8): 861-72; discussion 873-4.
3. Kala P.: The ESC Percutaneous Coronary Intervention Registry (ESC-PCI registry). ESC 2007 [online].
4. Leśniak W., Brożek J., Jaeschke R. et al.: Ocena informacji o metodzie leczniczej, rokowaniu lub szkodliwości. W: Podstawy EBM, czyli medycyny opartej na danych naukowych dla lekarzy i studentów medycyny. Gajewki P., Jaeschke R., Brożek J. (red.): Medycyna Praktyczna, Kraków 2008: 54-61, 69-74.
5. Center for Outcomes Research (COR) [online].
6. Hamm C.W., Bassand J.P., Agewall S. et al.: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2011 [Epub ahead of print].
7. Van de Werf F., Bax J., Betriu A. et al.: The Task Force on the management of ST-segment elevation acute The Task Force on the management of ST-segment elevation acute. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart J. 2008; 29(23): 2909-45.
8. Morrow D.A., Antman E.M., Charlesworth A. et al.: TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infracting myocardium early II trial substudy. Circulation 2000; 102: 2031-2037.
9. Crusadebleeding Score [online].
10. Hoekstra J.W., Pollack C.V. jr., Roe M.T. et al.: Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad. Emerg. Med. 2002; 9(11): 1146-55.
11. Poloński L., Gasior M., Gierlotka M. et al.: Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol. Pol. 2007; 65(8): 861-72; discussion 873-4.
12. Rejestr OZW [online].
13. Rejestr ZATPOL [online].
14. Teo K., Chow C.K., Vaz M. et al.: The Prospective Urban Rural Epidemiology (PURE) study: The Prospective Urban Rural Epidemiology (PURE) study: noncommunicable diseases in low-, middle-, and high-income countries. Am. Heart J. 2009; 158(1): 1-7.e1.
2. Poloński L., Gasior M., Gierlotka M. et al.: Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol. Pol. 2007; 65(8): 861-72; discussion 873-4.
3. Kala P.: The ESC Percutaneous Coronary Intervention Registry (ESC-PCI registry). ESC 2007 [online].
4. Leśniak W., Brożek J., Jaeschke R. et al.: Ocena informacji o metodzie leczniczej, rokowaniu lub szkodliwości. W: Podstawy EBM, czyli medycyny opartej na danych naukowych dla lekarzy i studentów medycyny. Gajewki P., Jaeschke R., Brożek J. (red.): Medycyna Praktyczna, Kraków 2008: 54-61, 69-74.
5. Center for Outcomes Research (COR) [online].
6. Hamm C.W., Bassand J.P., Agewall S. et al.: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2011 [Epub ahead of print].
7. Van de Werf F., Bax J., Betriu A. et al.: The Task Force on the management of ST-segment elevation acute The Task Force on the management of ST-segment elevation acute. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart J. 2008; 29(23): 2909-45.
8. Morrow D.A., Antman E.M., Charlesworth A. et al.: TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infracting myocardium early II trial substudy. Circulation 2000; 102: 2031-2037.
9. Crusadebleeding Score [online].
10. Hoekstra J.W., Pollack C.V. jr., Roe M.T. et al.: Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad. Emerg. Med. 2002; 9(11): 1146-55.
11. Poloński L., Gasior M., Gierlotka M. et al.: Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol. Pol. 2007; 65(8): 861-72; discussion 873-4.
12. Rejestr OZW [online].
13. Rejestr ZATPOL [online].
14. Teo K., Chow C.K., Vaz M. et al.: The Prospective Urban Rural Epidemiology (PURE) study: The Prospective Urban Rural Epidemiology (PURE) study: noncommunicable diseases in low-, middle-, and high-income countries. Am. Heart J. 2009; 158(1): 1-7.e1.